This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Sophora flavescens (Ku Shen) is a traditional Chinese medicinal herb used for its anti-inflammatory, antimicrobial, and antitumor properties [PMID:26087234, 35358931].
Background
Sophora flavescens, also known as Kushen, is a medicinal plant widely distributed in China and Japan [PMID:38397194, 33490578]. It has been utilized in East Asian medicine since the Qin and Han dynasties [PMID:26087234, 35358931].
Traditional uses
Traditionally used to treat fever, dysentery, hematochezia, jaundice, oliguria, vulvar swelling, asthma, eczema, inflammatory disorders, ulcers, skin burns, diarrhea, and vaginal itching [PMID:26087234, 38797379, 40850660]. It is also recognized for heat-clearing, damp-drying, insecticidal, and diuretic properties [PMID:38864547, 35358931].
Active compounds
Key bioactive compounds include quinolizidine alkaloids such as matrine, oxymatrine, and sophocarpine [PMID:27150374, 38746009], as well as prenylated flavonoids including kurarinone, sophoraflavanone G, and kushenols A and I [PMID:38397194, 37137428]. Other identified components include formononetin, hyperforin, and various pterocarpan glycosides [PMID:40635516, 37116554, 35583301].
Mechanism of action
Mechanisms include suppression of microglia activation via the NF-κB signaling pathway [PMID:35217618], membrane disruption of bacteria [PMID:37137428], suppression of neutrophil extracellular traps (NETs) [PMID:40635516], and modulation of ROS/MAPK/autophagy responses [PMID:40850660]. Some components exhibit estrogenic activity mediated by estrogen receptors [PMID:38397194] and target the PI3K-AKT/ICAM1 axis [PMID:37116554].
Sophora flavescens has shown potential analgesic and anti-cancer properties [PMID:39629083]
Evidence CBreast Cancer
Matrine, oxymatrine, and Compound Kushen Injection (CKI) are used to inhibit proliferation, invasion, and migration of breast cancer cells and relieve chemotherapy side effects [PMID:32161498]
Evidence DUlcerative Colitis
Oxymatrine alleviates colitis by improving inflammation and ferroptosis [PMID:38797379]; SF-derived nanovesicles carrying CX5461 ameliorate DSS-induced colitis in mice [PMID:39379937]
Evidence DParkinson's Disease
Kurarinone alleviated behavioral deficits and dopaminergic neurotoxicity in animal models by stabilizing epoxyeicosatrienoic acids [PMID:35217618]
Evidence DAtopic Dermatitis
Formononetin alleviates AD by suppressing neutrophil extracellular traps [PMID:40635516]
Evidence D
Safety & adverse effects
Matrine is noted for potential toxicity to the central nervous system [PMID:37570750]. However, aqueous root extract was classified as non-irritant in in vitro skin and eye irritation tests [PMID:42198524].
Evidence summary
Evidence is primarily based on in vitro studies, animal models (D), and a few reviews (C). One systematic review/meta-analysis (A) exists regarding bone neuropathic pain, though the overall clinical evidence for human use remains fragmented.
PubMed sources
1.PMID: 39379937 (2024) — Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice. · Journal of nanobiotechnology
2.PMID: 35217618 (2022) — Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model. · Proceedings of the National Academy of Sciences of the United States of America
3.PMID: 37137428 (2024) — Antimicrobial activities of lavandulylated flavonoids in Sophora flavences against methicillin-resistant Staphylococcus aureus via membrane disruption. · Journal of advanced research
4.PMID: 38797379 (2024) — Beneficial effects of oxymatrine from Sophora flavescens on alleviating Ulcerative colitis by improving inflammation and ferroptosis. · Journal of ethnopharmacology
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
Sophoraflavanone G and kurarinone exhibit antimicrobial activity against methicillin-resistant Staphylococcus aureus via membrane disruption [PMID:37137428]
(2018)
— Structural Modifications of Matrine-Type Alkaloids.
· Mini reviews in medicinal chemistry
6.PMID: 27150374 (2016) — Matrine: Bioactivities and Structural Modifications. · Current topics in medicinal chemistry
12.PMID: 40850660 (2026) — Sophora flavescens Aiton alleviates particulate matter-exacerbated asthma through modulation of ROS/ MAPK/autophagy responses. · Journal of ethnopharmacology
13.PMID: 33490578 (2018) — Characterization of the complete chloroplast genome of shrubby sophora (Sophora flavescens Ait.). · Mitochondrial DNA. Part B, Resources
14.PMID: 32924588 (2022) — Quinolizidine alkaloids from the roots of Sophora flavescens. · Natural product research
15.PMID: 38746009 (2024) — A review on the pharmacology, pharmacokinetics and toxicity of sophocarpine. · Frontiers in pharmacology
16.PMID: 26087234 (2015) — Sophora flavescens Ait.: Traditional usage, phytochemistry and pharmacology of an important traditional Chinese medicine. · Journal of ethnopharmacology
17.PMID: 37743030 (2023) — Alkaloids from the roots of Sophora flavescens and their anti-tumor activity. · Fitoterapia
18.PMID: 38864547 (2024) — Prenylated Flavonoids in Sophora flavescens: A Systematic Review of Their Phytochemistry and Pharmacology. · The American journal of Chinese medicine
19.PMID: 32194169 (2020) — Phytochemistry and biological properties of isoprenoid flavonoids from Sophora flavescens Ait. · Fitoterapia
20.PMID: 37570750 (2023) — Research Progress of Natural Matrine Compounds and Synthetic Matrine Derivatives. · Molecules (Basel, Switzerland)
21.PMID: 32161498 (2020) — Anti-Tumor Activities of Bioactive Phytochemicals in Sophora flavescens for Breast Cancer. · Cancer management and research
22.PMID: 37116554 (2023) — Hyperforin regulates renal fibrosis via targeting the PI3K-AKT/ICAM1 axis. · Cellular signalling
23.PMID: 10654410 (1999) — Antibacterial and antiandrogen flavonoids from Sophora flavescens. · Journal of natural products
24.PMID: 40935216 (2026) — Combining metabolomics and network pharmacology to clarify the mechanism of Angelica sinensis-Sophora flavescens pills in treating atopic dermatitis through the sweet-bitter harmonization theory. · Journal of ethnopharmacology
25.PMID: 35358931 (2022) — Chemical diversity, biological activities and Traditional uses of and important Chinese herb Sophora. · Phytomedicine : international journal of phytotherapy and phytopharmacology
26.PMID: 39629083 (2024) — Meta-analysis of the effect of sophora flavescens on tumor metastasis-induced bone neuropathic pain. · Frontiers in pharmacology
27.PMID: 40822926 (2025) — Sophora flavescens-derived extracellular vesicles loaded with oncolytic vaccinia virus/IR1061 for NIR-II photoacoustic imaging guided multimodal treatment of diffuse large B-cell lymphoma. · Materials today. Bio
28.PMID: 29173048 (2018) — Nonspecific Symbiosis Between Sophora flavescens and Different Rhizobia. · Molecular plant-microbe interactions : MPMI
29.PMID: 42198524 (2026) — Safety Assessment of Sophora flavescens Root Extract for Cosmetic Use: An Integrated Approach Using In Vitro, In Silico MoS, TTC, and History of Safe Use. · Toxics